America’s Prescription Problem: Drug Affordability Remains Out of Reach

The Alliance of Community Health Plans (ACHP) America’s Prescription Problem issue brief highlights how skyrocketing drug prices, monopolized supply chains and inadequate market protections continue to put essential medicines out of reach for patients, while outlining six targeted policy solutions to build a fairer, more affordable drug marketplace.

Citations:

1. “RFK Jr. Criticizes Big Pharma Profits During Senate HELP Committee Confirmation Hearing.” Pharmaceutical Reform Alliance. January 30, 2025. https://achp.pub/PRA_Profits 
2. McGough, Matt et al. “How much is health spending expected to grow?” Peterson-KFF Health System Tracker. August 4, 2025. https://achp.pub/Health_Spending_Growth 
3. Phares, Sharon et al. “Managing the Challenges of Paying for Gene Therapy: Strategies for Market Action and Policy Reform.” Institute for Clinical and Economic Review. April 23, 2024. https://achp.pub/ICER_Gene_Therapy 
4. “Generic and Biosimilar Medicines Save $467 Billion in 2024.” Biosimilars Council. September 3, 2025. https://achp.pub/Biosimilar_Savings_2024 
5. “Prescription Drugs: Medicare Spending on Drugs with Direct-to-Consumer Advertising.” U.S. Government Accountability Office. May 18, 2021. https://achp.pub/GAO_Medicare_Spend 
6. Martin, Kristi. “What Pharmacy Benefit Managers Do, and How They Contribute to Drug Spending.” The Commonwealth Fund. March 17, 2025. https://achp.pub/PBM_Drug_Spending